Literature DB >> 30936351

Ocular infiltration as initial presentation of acute monocytic leukaemia transformed from chronic myelomonocytic leukaemia associated with BRAF V600E mutation.

Aditya Tedjaseputra1, Fathima Shahla Vilcassim1,2, George Grigoriadis1,2.   

Abstract

Acute monocytic leukaemia (French-British-American classification: AML-M5b) is characterised by a predominance of cells of the monocytic lineage on bone marrow examination. Furthermore, a discerning feature is its tendency for tissue infiltration. While gum hypertrophy and hepatosplenomegaly are common, ocular involvement is rare. Here, we present a case of a 75-year-old man referred with proptosis and monocytosis-subsequently diagnosed as AML-M5b, whose disease course was distinguished by extensive tissue invasion (ocular, pulmonary, liver, spleen). Cytogenetics and molecular tests were consistent with blastic transformation of previously undiagnosed chronic myelomonocytic leukaemia, supported by the presence of long-standing, low-grade monocytosis. Notably, a BRAF V600E mutation was also detected-an oncogenic driver previously reported in de novo and therapy-related, but not chronic myelomonocytic leukaemia-transformed, AML-M5b. While an initial response to cytoreductive treatment was observed, his tissue-invasive disease soon progressed with worsening pulmonary infiltrates, disseminated intravascular coagulation and renal failure, resulting in death. © BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  carcinogenesis; haematology (incl blood transfusion); pathology

Mesh:

Substances:

Year:  2019        PMID: 30936351      PMCID: PMC6453331          DOI: 10.1136/bcr-2018-228519

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  13 in total

1.  Blast transformation in chronic myelomonocytic leukemia: Risk factors, genetic features, survival, and treatment outcome.

Authors:  Mrinal M Patnaik; Emnet A Wassie; Terra L Lasho; Curtis A Hanson; Rhett Ketterling; Ayalew Tefferi
Journal:  Am J Hematol       Date:  2015-04-01       Impact factor: 10.047

2.  BRAF kinase domain mutations are present in a subset of chronic myelomonocytic leukemia with wild-type RAS.

Authors:  Liping Zhang; Rajesh R Singh; Keyur P Patel; Francesco Stingo; Mark Routbort; M James You; Roberto N Miranda; Guillermo Garcia-Manero; Hagop M Kantarjian; L Jeffrey Medeiros; Rajyalakshmi Luthra; Joseph D Khoury
Journal:  Am J Hematol       Date:  2014-02-10       Impact factor: 10.047

3.  Mutations of genes in the receptor tyrosine kinase (RTK)/RAS-BRAF signal transduction pathway in therapy-related myelodysplasia and acute myeloid leukemia.

Authors:  D H Christiansen; M K Andersen; F Desta; J Pedersen-Bjergaard
Journal:  Leukemia       Date:  2005-12       Impact factor: 11.528

4.  Unilateral Eye Findings: A Rare Herald of Acute Leukemia.

Authors:  Avni V Patel; John B Miller; Rajneesh Nath; Helen A Shih; Michael K Yoon; Suzanne K Freitag; George Papaliodis; Teresa C Chen; Dean Eliott; Ivana K Kim
Journal:  Ocul Oncol Pathol       Date:  2016-01-13

5.  How I treat extramedullary acute myeloid leukemia.

Authors:  Richard L Bakst; Martin S Tallman; Dan Douer; Joachim Yahalom
Journal:  Blood       Date:  2011-07-27       Impact factor: 22.113

Review 6.  BRAFV600E: implications for carcinogenesis and molecular therapy.

Authors:  Emma R Cantwell-Dorris; John J O'Leary; Orla M Sheils
Journal:  Mol Cancer Ther       Date:  2011-03       Impact factor: 6.261

Review 7.  How I treat chronic myelomonocytic leukemia.

Authors:  Eric Solary; Raphael Itzykson
Journal:  Blood       Date:  2017-06-01       Impact factor: 22.113

8.  Acute monocytic leukemia presenting as acute respiratory failure.

Authors:  Elie Azoulay; Fabienne Fieux; Delphine Moreau; Guillaume Thiery; Philippe Rousselot; Antoine Parrot; Jean-Roger Le Gall; Hervé Dombret; Benoît Schlemmer
Journal:  Am J Respir Crit Care Med       Date:  2003-02-05       Impact factor: 21.405

Review 9.  The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.

Authors:  Daniel A Arber; Attilio Orazi; Robert Hasserjian; Jürgen Thiele; Michael J Borowitz; Michelle M Le Beau; Clara D Bloomfield; Mario Cazzola; James W Vardiman
Journal:  Blood       Date:  2016-04-11       Impact factor: 22.113

Review 10.  Trisomy 5 in two cases of acute monocytic leukemia with hyperdiploid clones.

Authors:  S K Ma; T S Wan; W Y Au; L C Chan
Journal:  Leuk Res       Date:  1998-10       Impact factor: 3.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.